Our Story
Founded in 2022, Theta Neurotech initially set out to develop a "FitBit for the Brain." Our mission pivoted in 2023 when a personal experience with uncontrolled seizures revealed a critical need in healthcare. Recognizing that our expertise in neurotechnology could address this pressing issue, we refocused our efforts on early seizure detection and prediction.
At Theta Neurotech, we're dedicated to empowering individuals with epilepsy and seizure disorders. Our goal is to provide timely alerts and greater control, transforming the unpredictable nature of seizures into something more manageable. We work tirelessly to develop innovative solutions that bring peace of mind and improve the quality of life for those affected by seizure disorders.
Leadership Team
-
Truman Pierson
FOUNDER, CEO
-
Christopher Fitz
FOUNDER, CTO
-
Naoum Issa, MD, PhD
PRINCIPAL INVESTIGATOR
-
Nathan Fountain, MD
SCIENTIFIC ADVISOR
-
Vikram Rao, MD, PhD
SCIENTIFIC ADVISOR
-
Devjani Saha, PhD
REGULATORY CONSULTANT
-
John McDermott, MBA
MARKET ACCESS CONSULTANT
-
Alyssa Eckerly-Case, JD
IP COUNSEL
Offices
Chicago
222 N La Salle St,
Chicago, IL 60601